# Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

> **NCT01735175** · PHASE3 · COMPLETED · sponsor: **Sandoz** · enrollment: 316 (actual)

## Conditions studied

- Neutropenic Complications
- Breast Neoplasms
- Chemotherapy-induced Neutropenia
- Chemotherapeutic Toxicity

## Interventions

- **DRUG:** LA-EP2006
- **DRUG:** Neulasta®

## Key facts

- **NCT ID:** NCT01735175
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-05
- **Final completion:** 2014-02
- **Target enrollment:** 316 (ACTUAL)
- **Last updated:** 2017-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01735175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01735175, "Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01735175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*